시장보고서
상품코드
2040854

첨가제 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 제형별, 기능별, 지역별 및 부문별 예측(2026-2033년)

Excipients Market Size, Share & Trends Analysis Report By Product (Polymers, Alcohols, Sugars, Minerals, Gelatin), By Formulation (Oral, Topical), By Function, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 8,864,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,354,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,333,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

첨가제 시장 요약

세계의 첨가제 시장 규모는 2025년에 106억 9,068만 달러로 추계되며, 2033년까지 147억 4,668만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 4.11%로 성장할 것으로 전망되고 있습니다.

부형제는 의약품의 기능을 향상시키고 제제에서 경쟁 우위를 가져다주는 것으로서 점점 더 중요시되고 있으며, 제약 기업 사이에서 널리 채택되고 있습니다.

약물전달 효율을 향상시키기 위한 최적화된 첨가제의 지속적인 연구개발은 시장 성장을 촉진하고 있으며, 보다 진보되고 다기능적인 첨가제에 대한 추세는 현재 제약업계의 동향을 형성하고 있습니다. 부형제는 의약품의 기능을 향상시키고 환자의 치료 결과를 개선하는 데 중요한 역할을 하고 있으며, 제약 기업에서 광범위하게 채택되고 있습니다. 암, 대사성 질환, 만성질환의 치료에서 나노입자를 이용한 약물전달 및 표적 치료를 지원하는 첨단 부형제에 대한 수요가 증가하면서 혁신과 채택을 촉진하고 있습니다. 주요 의약품의 특허 만료도 안정성, 용해도 및 생체이용률을 향상시키기 위해 다기능 부형제를 사용하여 최적화된 제제 개발을 촉진하고 있습니다.

제약회사들은 현재 바이오의약품과의 호환성, 서방형 제제, 환자 친화적인 전달 시스템에 초점을 맞춰 차세대 첨가제 연구개발에 적극 나서고 있습니다. 예를 들어 2025년 12월 화이자와 시플라는 인도에서 전략적 제휴를 체결했습니다. 이번 제휴를 통해 시플라는 화이자의 주요 브랜드 4개 제품을 국내에서 독점적으로 판매 및 유통하게 되며, 화이자의 기존 제품과 시플라의 광범위한 유통망을 결합하여 전국적으로 필수 의약품에 대한 접근성을 확대할 수 있게 되었습니다. 이는 제형 및 약물전달 기술의 혁신을 촉진하는 데 있으며, 협업의 역할을 강조합니다.

바이오베터빌리티(생체 이용률)와 환자 복약 순응도 강화를 목표로 하는 기업이 늘어나면서 개인 맞춤형 약물전달에 대한 관심이 높아지고 있으며, 이는 첨가제 혁신을 더욱 촉진하고 있습니다. Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries 등의 기업은 경구제, 주사제, 서방형 제제를 위한 다기능 첨가제를 연구하고 있습니다. 제약기업과 특수화학기업과의 제휴가 증가함에 따라 복잡한 치료에 적합한 안정적이고 고성능의 첨가제 개발이 가속화되고 있습니다. 또한 나노입자 제제 및 생물제제에 첨가제를 통합함으로써 표적 치료 전략에서 첨가제의 역할이 확대되고 있습니다. 규제 당국도 안전과 품질을 보장하면서 업데이트된 가이드라인을 통해 첨단 첨가제 채택을 장려하고 있습니다. 이러한 추세와 함께 향후 수년간 첨가제 분야의 강력한 성장과 혁신이 지속될 것으로 예상됩니다.

자주 묻는 질문

  • 첨가제 시장 규모는 어떻게 예측되나요?
  • 첨가제가 제약업계에서 중요한 이유는 무엇인가요?
  • 첨가제의 연구개발 동향은 어떤가요?
  • 첨가제의 혁신을 촉진하는 요인은 무엇인가요?
  • 제약기업과 특수화학기업 간의 협력은 어떤 영향을 미치고 있나요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 첨가제 시장 : 변수, 동향, 범위

제4장 첨가제 시장 : 제품별 비즈니스 분석

제5장 첨가제 시장 : 제제별 비즈니스 분석

제6장 첨가제 시장 : 기능별 비즈니스 분석

제7장 첨가제 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

KSA 26.06.02

Excipients Market Summary

The global excipients market size was estimated at USD 10,690.68 million in 2025 and is projected to reach USD 14,746.68 million by 2033, growing at a CAGR of 4.11% from 2026 to 2033. Excipients are increasingly valued for enhancing drug functionality and offering a competitive edge in formulations, driving their widespread adoption among pharmaceutical companies.

Continuous research and development of optimized excipients for improved drug delivery have strengthened market growth, while the trend toward more advanced, multifunctional excipients is shaping the current pharmaceutical landscape. Excipients continue to play a critical role in enhancing drug functionality and improving patient outcomes, driving widespread adoption among pharmaceutical companies. Rising demand for advanced excipients that support nanoparticle drug delivery and targeted therapies in oncology, metabolic, and chronic disease treatments is boosting innovation and adoption. Patent expirations of major drugs are also encouraging the development of optimized formulations with multifunctional excipients to improve stability, solubility, and bioavailability.

Pharmaceutical firms are now actively engaged in R&D for next-generation excipients, focusing on compatibility with biologics, sustained-release formulations, and patient-friendly delivery systems. For instance, in December 2025, Pfizer Inc. and Cipla Ltd. entered a strategic partnership in India under which Cipla will exclusively market and distribute four key Pfizer brands across the country, combining Pfizer's established products with Cipla's extensive distribution network to expand access to essential medications nationwide, highlighting the role of collaborations in advancing drug formulation and delivery innovation.

The growing emphasis on customized drug delivery is further driving excipient innovation, as companies aim to improve bioavailability and patient compliance. Firms like Novartis AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd. are exploring multifunctional excipients for oral, injectable, and sustained-release formulations. Increasing collaborations between pharmaceutical and specialty chemical companies are accelerating the development of stable, high-performance excipients suitable for complex therapies. In addition, the integration of excipients in nanoparticle and biologic formulations is expanding their role in targeted treatment strategies. Regulatory agencies are also encouraging the adoption of advanced excipients through updated guidelines, ensuring safety and quality. Together, these trends are expected to sustain robust growth and innovation in the excipients sector over the coming years.

Global Excipients Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global excipients market report based on product, formulation, function, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymers
    • MCC
    • HPMC
    • Ethyl Cellulose
    • Methyl Cellulose
    • CMC
    • Croscarmellose Sodium
    • Povidone
    • Pregelatinized starch
    • Sodium starch glycolate
    • Polyethylene Glycol
    • Acrylic Polymers
  • Alcohols
    • Glycerin
    • Propylene Glycol
    • Sorbitol
    • Mannitol
    • Others
  • Sugar
    • Lactose
    • Sucrose
    • Others
  • Minerals
    • Calcium Phosphate
    • Calcium Carbonate
    • Clay
    • Silicon Dioxide
    • Titanium Dioxide
    • Others
  • Gelatin
  • Formulation Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Topical
  • Parenteral
  • Others
  • Function Outlook (Revenue, USD Million, 2021 - 2033)
  • Fillers and Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Formulation
    • 1.2.3. Function
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Excipients Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Excipients Market: Product Business Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Polymers
    • 4.4.1. Polymers Market, 2021 - 2033 (USD Million)
    • 4.4.2. MCC
      • 4.4.2.1. MCC Market, 2021 - 2033 (USD Million)
    • 4.4.3. HPMC
      • 4.4.3.1. HPMC Market, 2021 - 2033 (USD Million)
    • 4.4.4. Ethyl Cellulose
      • 4.4.4.1. Ethyl Cellulose Market, 2021 - 2033 (USD Million)
    • 4.4.5. Methyl Cellulose
      • 4.4.5.1. Methyl Cellulose Market, 2021 - 2033 (USD Million)
    • 4.4.6. CMC
      • 4.4.6.1. CMC Market, 2021 - 2033 (USD Million)
    • 4.4.7. Croscarmellose Sodium
      • 4.4.7.1. Croscarmellose Sodium Market, 2021 - 2033 (USD Million)
    • 4.4.8. Povidone
      • 4.4.8.1. Povidone Market, 2021 - 2033 (USD Million)
    • 4.4.9. Pregelatinized starch
      • 4.4.9.1. Pregelatinized starch Market, 2021 - 2033 (USD Million)
    • 4.4.10. Sodium starch glycolate
      • 4.4.10.1. Sodium starch glycolate Market, 2021 - 2033 (USD Million)
    • 4.4.11. Polyethylene Glycol
      • 4.4.11.1. Polyethylene Glycol Market, 2021 - 2033 (USD Million)
    • 4.4.12. Acrylic Polymers
      • 4.4.12.1. Acrylic Polymers Market, 2021 - 2033 (USD Million)
  • 4.5. Alcohols
    • 4.5.1. Alcohols Market, 2021 - 2033 (USD Million)
    • 4.5.2. Glycerin
      • 4.5.2.1. Glycerin Market, 2021 - 2033 (USD Million)
    • 4.5.3. Propylene Glycol
      • 4.5.3.1. Propylene Glycol Market, 2021 - 2033 (USD Million)
    • 4.5.4. Sorbitol
      • 4.5.4.1. Sorbitol Market, 2021 - 2033 (USD Million)
    • 4.5.5. Mannitol
      • 4.5.5.1. Mannitol Market, 2021 - 2033 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2021 - 2033 (USD Million)
  • 4.6. Sugar
    • 4.6.1. Sugar Market, 2021 - 2033 (USD Million)
    • 4.6.2. Lactose
      • 4.6.2.1. Lactose Market, 2021 - 2033 (USD Million)
    • 4.6.3. Sucrose
      • 4.6.3.1. Sucrose Market, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market, 2021 - 2033 (USD Million)
  • 4.7. Minerals
    • 4.7.1. Minerals Market, 2021 - 2033 (USD Million)
    • 4.7.2. Calcium Phosphate
      • 4.7.2.1. Calcium Phosphate Market, 2021 - 2033 (USD Million)
    • 4.7.3. Calcium Carbonate
      • 4.7.3.1. Calcium Carbonate Market, 2021 - 2033 (USD Million)
    • 4.7.4. Clay
      • 4.7.4.1. Clay Market, 2021 - 2033 (USD Million)
    • 4.7.5. Silicon Dioxide
      • 4.7.5.1. Silicon Dioxide Market, 2021 - 2033 (USD Million)
    • 4.7.6. Titanium Dioxide
      • 4.7.6.1. Titanium Dioxide Market, 2021 - 2033 (USD Million)
    • 4.7.7. Others
      • 4.7.7.1. Others Market, 2021 - 2033 (USD Million)
  • 4.8. Gelatin
    • 4.8.1. Gelatin Market, 2021 - 2033 (USD Million)

Chapter 5. Excipients Market: Formulation Business Analysis

  • 5.1. Formulation Market Share, 2025 & 2033
  • 5.2. Formulation Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Topical
    • 5.5.1. Topical Market, 2021 - 2033 (USD Million)
  • 5.6. Parenteral
    • 5.6.1. Parenteral Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Excipients Market: Function Business Analysis

  • 6.1. Function Market Share, 2025 & 2033
  • 6.2. Function Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Function, 2021 to 2033 (USD Million)
  • 6.4. Fillers and Diluents
    • 6.4.1. Fillers and Diluents Market, 2021 - 2033 (USD Million)
  • 6.5. Suspending & Viscosity Agents
    • 6.5.1. Suspending & Viscosity Agents Market, 2021 - 2033 (USD Million)
  • 6.6. Coating Agents
    • 6.6.1. Coating Agents Market, 2021 - 2033 (USD Million)
  • 6.7. Binders
    • 6.7.1. Binders Market, 2021 - 2033 (USD Million)
  • 6.8. Flavoring Agents & Sweeteners
    • 6.8.1. Flavoring Agents & Sweeteners Market, 2021 - 2033 (USD Million)
  • 6.9. Disintegrants
    • 6.9.1. Disintegrants Market, 2021 - 2033 (USD Million)
  • 6.10. Colorants
    • 6.10.1. Colorants Market, 2021 - 2033 (USD Million)
  • 6.11. Lubricants and Glidants
    • 6.11.1. Lubricants and Glidants Market, 2021 - 2033 (USD Million)
  • 6.12. Preservatives
    • 6.12.1. Preservatives Market, 2021 - 2033 (USD Million)
  • 6.13. Emulsifying Agents
    • 6.13.1. Emulsifying Agents Market, 2021 - 2033 (USD Million)
  • 6.14. Others
    • 6.14.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Excipients Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Excipients Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Reimbursement Framework
      • 7.4.2.4. U.S. Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Reimbursement Framework
      • 7.4.3.4. Canada Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Reimbursement Framework
      • 7.4.4.4. Mexico Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Reimbursement Framework
      • 7.5.2.4. UK Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Reimbursement Framework
      • 7.5.3.4. Germany Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Reimbursement Framework
      • 7.5.4.4. France Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Reimbursement Framework
      • 7.5.5.4. Italy Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Reimbursement Framework
      • 7.5.6.4. Spain Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Reimbursement Framework
      • 7.5.7.4. Denmark Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Reimbursement Framework
      • 7.5.8.4. Sweden Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Reimbursement Framework
      • 7.5.9.4. Norway Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Reimbursement Framework
      • 7.6.2.4. Japan Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Reimbursement Framework
      • 7.6.3.4. China Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Reimbursement Framework
      • 7.6.4.4. India Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Reimbursement Framework
      • 7.6.5.4. Australia Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Reimbursement Framework
      • 7.6.6.4. South Korea Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Reimbursement Framework
      • 7.6.7.4. Thailand Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Reimbursement Framework
      • 7.7.2.4. Brazil Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Reimbursement Framework
      • 7.7.3.4. Argentina Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Reimbursement Framework
      • 7.8.2.4. South Africa Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Reimbursement Framework
      • 7.8.3.4. Saudi Arabia Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Reimbursement Framework
      • 7.8.4.4. UAE Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Reimbursement Framework
      • 7.8.5.4. Kuwait Excipients Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Eastman Chemical Corporation
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. P&G Chemicals
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Avantor Performance Materials, LLC
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Huntsman Corporation
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. BASF SE
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Ashland Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. FMC Corporation
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Roquette
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Colorcon Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Lubrizol Corporation
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기